Every record from Medutest · page 11
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020086 | BPC-157 | GGPeps | GGPE-2509-N7954 | 2025-Q4 | 98.88 | 3.80 | 89.5 | Supplier-supplied | 4 | MARGINAL |
| AX-2025-019718 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 98.96 | 7.31 | 97.0 | Supplier-supplied | 0 | PASS |
| AX-2025-018591 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.52 | 4.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020510 | TB-500 | KP | KP-2510-V5596 | 2025-Q4 | 99.26 | 4.57 | 100.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020019 | TB-500 | ERP | ERP-2511-L7123 | 2025-Q4 | 98.97 | 4.27 | 105.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-019634 | Semaglutide | Homopeptide | HOMO-2508-K2535 | 2025-Q4 | 99.04 | 3.60 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019389 | Retatrutide | Homopeptide | HOMO-2508-Y8363 | 2025-Q4 | 98.29 | 7.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020058 | Tirzepatide | ERP | ERP-2505-V8029 | 2025-Q4 | 97.22 | 4.85 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020779 | Tirzepatide | SGN | SGN-2505-G9671 | 2025-Q4 | 98.71 | 4.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019394 | Retatrutide | Homopeptide | HOMO-2508-Y8363 | 2025-Q4 | 98.43 | 7.30 | 105.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018668 | BPC-157 | QYB | QYB-2508-M5929 | 2025-Q4 | 99.93 | 4.49 | 105.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019932 | Mazdutide | SWB | SWB-2505-Y5355 | 2025-Q4 | 97.88 | 3.17 | 90.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018539 | Pramlintide | WWB | WWB-2511-L4181 | 2025-Q4 | 99.93 | 7.01 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020863 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.64 | 5.89 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-020084 | BPC-157 | GGPeps | GGPE-2509-N7954 | 2025-Q4 | 98.73 | 3.55 | 93.1 | Buyer-sourced | 4 | FAIL |
| AX-2025-019999 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | 2025-Q4 | 99.91 | 4.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020628 | Semaglutide | SSA | SSA-2510-C7247 | 2025-Q4 | 98.08 | 3.81 | 106.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020583 | Retatrutide | SSA | SSA-2510-E6502 | 2025-Q4 | 96.34 | 3.66 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020413 | Tirzepatide | KP | KP-2505-F4869 | 2025-Q4 | 96.73 | 6.08 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020226 | Cagrilintide | GGPeps | GGPE-2507-Y1706 | 2025-Q4 | 98.25 | 1.59 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019627 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 98.65 | 5.88 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019007 | CJC-1295 with DAC | JEEP | JEEP-2509-P2811 | 2025-Q4 | 99.51 | 4.26 | 96.2 | Supplier-supplied | 4 | MARGINAL |
| AX-2025-019970 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 98.67 | 6.63 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018957 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | 2025-Q4 | 99.93 | 3.53 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020448 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.04 | 2.44 | 90.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020870 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.66 | 6.44 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020511 | TB-500 | KP | KP-2510-V5596 | 2025-Q4 | 98.42 | 4.45 | 100.6 | Laboratory-retained | 2 | FAIL |
| AX-2025-020235 | MOTS-c | GGPeps | GGPE-2508-J1903 | 2025-Q4 | 99.18 | 4.41 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019631 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 98.39 | 5.67 | 106.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018462 | Tirzepatide | WWB | WWB-2506-T2732 | 2025-Q4 | 99.71 | 4.19 | 103.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020446 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.13 | 2.28 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019385 | BPC-157 | TFC | TFC-2511-C8532 | 2025-Q4 | 98.46 | 7.08 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019175 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.88 | 3.17 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020161 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.95 | 7.12 | 102.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019026 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U3035 | 2025-Q4 | 99.93 | 8.81 | 100.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019659 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | 2025-Q4 | 99.36 | 5.59 | 106.3 | Supplier-supplied | 0 | PASS |
| AX-2025-018625 | Retatrutide | QYB | QYB-2507-R5467 | 2025-Q4 | 97.79 | 3.86 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020866 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 98.51 | 5.87 | 103.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021196 | BPC-157 | BCH | BCH-2506-D6485 | 2025-Q4 | 98.95 | 6.23 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-021126 | Semaglutide | WXT | WXT-2509-A5382 | 2025-Q4 | 97.82 | 6.09 | — | Supplier-supplied | 1 | MARGINAL |